Amicus Therapeutics
FOLD
FOLD
227 hedge funds and large institutions have $3.63B invested in Amicus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 94 increasing their positions, 66 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
3.96% less ownership
Funds ownership: 107.97% → 104.01% (-4%)
6% less capital invested
Capital invested by funds: $3.86B → $3.63B (-$224M)
Holders
227
Holding in Top 10
7
Calls
$14.3M
Puts
$9.83M
Top Buyers
| 1 | +$98.1M | |
| 2 | +$28.6M | |
| 3 | +$5.7M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$5.22M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$5.18M |
Top Sellers
| 1 | -$74.3M | |
| 2 | -$73.6M | |
| 3 | -$31.9M | |
| 4 |
Morgan Stanley
New York
|
-$28.1M |
| 5 |
O
OrbiMed
New York
|
-$23.3M |